Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional, Non-interventional Burden Of Disease (Bod) Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (Ttr-fap) Or Transthyretin Cardiomyopathy (ttr-cm) And Caregivers

NCT01604122 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01604122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional, Non-interventional Burden Of Disease (Bod) Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (Ttr-fap) Or Transthyretin Cardiomyopathy (ttr-cm) And Caregivers
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
April 18, 2012
Completion date
July 18, 2016
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

familial amyloid cardiomyopathy, senile systemic amyloidosis (ssa), transthyretin cardiomyopathy (ttr-cm), transthyretin familial amyloidosis polyneuropathy (ttr-fap)